C. Mendiola
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
Papers in
- Oncology 14
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 4
- Lung Cancer Research Studies 2
-
- Ovarian cancer diagnosis and treatment 11
- Co-authors
- H. Cortés-Funes (13 shared papers)Jan B. Vermorken (2 shared papers)J. Lindtner (2 shared papers)Alan S. Coates (2 shared papers)Eva Ciruelos (6 shared papers)S. Pecorelli (2 shared papers)Silvia Dellapasqua (1 shared paper)Luis Paz‐Ares (2 shared papers)
In The Last Decade
C. Mendiola
28 papers receiving 374 citations
Peers
Comparison fields: 5 of 66
- Reproductive Medicine 93
- Obstetrics and Gynecology 69
- Oncology 185
- Cancer Research 67
- Surgery 97
Countries citing papers authored by C. Mendiola
This map shows the geographic impact of C. Mendiola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Mendiola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Mendiola more than expected).
Fields of papers citing papers by C. Mendiola
This network shows the impact of papers produced by C. Mendiola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Mendiola. The network helps show where C. Mendiola may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Mendiola, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 80 | |
| 2 | 2006 | 48 | |
| 3 | 1994 | 43 | |
| 4 | 2000 | 41 | |
| 5 | 2003 | 23 | |
| 6 | 2004 | 16 | |
| 7 | 2007 | 15 | |
| 8 | An international multicentre Phase III study of BAY 12-9566 (BAY) versus placebo in patients (pts) with advanced ovarian cancer (OVCA) responsive to primary surgery/Paclitaxel + Platinum containing chemotherapy (CT) | 2001 | 15 |
| 9 | 1998 | 13 | |
| 10 | 2009 | 10 | |
| 11 | 2012 | 10 | |
| 12 | 2013 | 9 | |
| 13 | 1993 | 9 | |
| 14 | 1997 | 8 | |
| 15 | 1982 | 8 | |
| 16 | Early clinical trial with quelamycin. | 1979 | 8 |
| 17 | A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results. | 1995 | 5 |
| 18 | 2017 | 4 | |
| 19 | 2001 | 4 | |
| 20 | 2012 | 4 |
About C. Mendiola
C. Mendiola is a scholar working on Oncology, Reproductive Medicine, Surgery, Cancer Research and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 388 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (11 papers), Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (5 papers), HER2/EGFR in Cancer Research (4 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), Endometrial and Cervical Cancer Treatments (2 papers), Chemotherapy-related skin toxicity (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Reproductive Medicine (93 citations), Obstetrics and Gynecology (69 citations), Oncology (185 citations), Cancer Research (67 citations) and Surgery (97 citations). C. Mendiola has collaborated with scholars based in Spain, Italy and France. Frequent co-authors include H. Cortés-Funes, Jan B. Vermorken, J. Lindtner, Alan S. Coates, Eva Ciruelos, S. Pecorelli, Silvia Dellapasqua, Luis Paz‐Ares, Marco Colleoni and C. Lhommé. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical & Translational Oncology, European Journal of Cancer and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.